Our
Mission
KOKO Medical Inc. is a medical device startup committed to saving the lives of mothers with innovative products that allow for rapid postpartum hemorrhage intervention.
Postpartum Hemorrhaging
If the uterine muscles do not contract sufficiently after childbirth (Uterine Atony), very heavy bleeding (postpartum hemorrhage) can occur. This can be life threatening. Post hemorrhage usually occurs within 24hrs of childbirth, with 80% caused by uterine atony.
140.1M Births Worldwide in 2020
10.8% of women experience PPH during childbirth (15+M)
With a 1% fatality rate, 150,000+ women will die each year due to PPH
Other severe complications of PPH include adult respiratory distress syndrome, renal failure, coagulopathy, shock, myocardial ischemia, hysterectomy, and long-term morbidity such as anemia.
The Solution
The KOKO™ Device is a catheter-based technology that encourages uterine contractions while removing excess blood to stop postpartum hemorrhaging.
Warning: KOKO Medical , Inc. is a development stage company and the KOKO™ system is not approved by the FDA
About Us
Together, the team behind KOKO Medical shares over 80 years of successful Medical Device Development Experience.
Leadership Team
Skott Greenhalgh, PhD
Co-Founder, Chief Executive Officer
Michael Wallace
Co-Founder, Chief Technology Officer
Cathy Unruh, MS
VP of Research & Development
Jason Keiser, MBA
Co-Founder, VP of Operations
Contact Us
